Soleus Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Soleus Capital Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.5M	Sell	101,684 -20,000	-16%	-$588K	0.12%	81
2026 Q1	$3.76M	Buy	+121,684	New	+$2.99M	0.15%	71
2025 Q4	–	Sell	-25,000	Closed	-$392K	–	119
2025 Q3	$392K	Sell	25,000 -51,841	-67%	-$1.07M	0.02%	83
2025 Q2	$1.53M	Hold	76,841	–	–	0.1%	80
2025 Q1	$1.36M	Buy	76,841 +45,000	+141%	+$1.47M	0.1%	69
2024 Q4	$1.47M	Buy	+31,841	New	+$1.35M	0.09%	71

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Soleus Capital Management's TECX Position: Q2 2026 in Review

Soleus Capital Management reduced its Tectonic Therapeutic (TECX) stake by 16% in Q2 2026, selling an estimated $588K and leaving 101,684 shares worth $3.5M. The position accounts for 0.12% of the portfolio, ranked #81.

Soleus Capital Management first reported a position in TECX in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.76M in Q1 2026. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

Soleus Capital Management held 101,684 shares of Tectonic Therapeutic worth $3.5M as of Q2 2026.
Soleus Capital Management sold 20,000 Tectonic Therapeutic shares in Q2 2026, an estimated $588K.
Tectonic Therapeutic made up 0.12% of Soleus Capital Management's portfolio in Q2 2026, its #81 holding.
Soleus Capital Management first reported a position in Tectonic Therapeutic in Q4 2024 and has held it in 6 quarters since.
Soleus Capital Management's Tectonic Therapeutic position peaked at $3.76M in Q1 2026.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.